johnson & johnson news

Johnson & Johnson's Spravato nasal spray okayed

Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

UPI News on MSN · 2d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Business Insider · 2d

JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression

Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with treatment-resistant depression, a psychiatric disorder.

Ben Johnson introduced

USA Today · 1d

Ben Johnson introduced as Bears head coach: 'I wanted to stay in this division'

Ben Johnson expressed gratitude for his time with the Detroit Lions head coach, calling Dan Campbell a "friend" and "mentor" as he takes over Bears

NBC Sports on MSN · 1d

Ben Johnson takes dig at Packers coach Matt LaFleur

Ben Johnson had his choice of several jobs. He chose the Bears. Not only do they have a quarterback to build around, but Johnson also noted they are in a division with which he is familiar. Johnson spent six seasons in the NFC North as an assistant under Dan Campbell.

FOXSports on MSN · 6h

Bears coach Ben Johnson says his offense won't 'look the same as it did in Detroit'

New Bears HC Ben Johnson joined FS1's "Breakfast Ball" and "The Herd" to share what he might do to unlock Caleb Williams' potential.

Cam Johnson, Nets blocking out trade rumors

Bleacher Report · 1d

NBA Rumors: Kings Not in Cam Johnson Talks, Will Aggressively Explore Trade Options

Don't expect the Sacramento Kings to swing a deal for Brooklyn Nets' wing Cam Johnson. According to NBA reporter Marc Stein, the Kings have been

The New York Times · 17h

Why Nets’ Cam Johnson is a coveted player as NBA trade deadline nears

Cam Johnson, the soon-to-be 29-year-old Brooklyn Nets wing, has been arguably their best player overall this season. Let’s explore what makes Johnson one of the hottest options on the trade market. Johnson is the 3-and-D prototype,

New York Post on MSN · 1d

Nets’ Cam Johnson tuning out trade rumors swirling around him

Cam Johnson knows what time it is. Or more accurately, what time of year it is. With this a rebuilding year for the Nets, Johnson knew his name would come up in trade rumors. And with the Feb. 6 deadline just two weeks away,

Lions were prepared to lose Ben Johnson and Aaron Glenn

MLive · 1d

Lions WR warns Ben Johnson: ‘We’re going to (bleep) you up’

Amon-Ra St. Brown said he and Johnson already got into some playful banter his now-former OC called him after taking the Bears job.

NBC Sports on MSN · 18h

Brad Holmes: Lions were prepared to lose Ben Johnson and Aaron Glenn

Lions General Manager Brad Holmes says the coaching staff in Detroit will remain a strong one, despite losing offensive coordinator Ben Johnson to the Bears and defensive coordinator Aaron Glenn to the Jets.

FOX News on MSN · 1d

Lions losing Ben Johnson to rival Bears is big 'body blow,' Super Bowl champion says

Super Bowl champion Lomas Brown talked about the Detroit Lions losing top coordinator Ben Johnson to the Chicago Bears in a recent appearance on OutKick's "Don't @ Me with Dan Dakich."

14h

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

21h

Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

Johnson & Johnson Tops Q4 EPS Forecasts

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

1don MSN

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth

Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its ...

20h

Johnson & Johnson price target lowered to $165 from $170 at Raymond James

Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.

MassDevice1d

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

1don MSN

Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness

Johnson & Johnson (JNJ) traded flat after exceeding Street forecasts with its Q4 2024 results thanks mainly to its Innovative ...

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results